Thu, February 13, 2025
[ Thu, Feb 13th ] - MSN
ASX 200 strikes new record high
Wed, February 12, 2025

Up 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success'


//stocks-investing.news-articles.net/content/202 .. -to-become-a-truly-great-australian-success.html
Published in Stocks and Investing on Wednesday, February 12th 2025 at 21:21 GMT by MSN   Print publication without navigation

  • A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock. The post Up 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success' appeared first on The Motley Fool Australia.

The article discusses the significant growth of Pro Medicus (ASX: PME), an ASX 200 healthcare stock, which has seen its share price increase by 135% over the past year. Pro Medicus, a medical imaging software company, has benefited from a surge in demand for its services, particularly in the US where it earns most of its revenue. The company's success is attributed to its proprietary technology, Visage 7, which has been adopted by major US health systems, leading to a 35% increase in revenue and a 40% rise in net profit after tax in the first half of FY24. The article highlights the company's strategic focus on the US market, its recurring revenue model, and the potential for further growth as it continues to expand its market share. Despite its high valuation, the article suggests that Pro Medicus could still be a good investment due to its strong growth prospects and the increasing global demand for efficient medical imaging solutions.

Read the Full MSN Article at:
[ https://www.msn.com/en-au/money/top-stocks/up-135-in-a-year-why-this-asx-200-healthcare-stock-is-on-track-to-become-a-truly-great-australian-success/ar-AA1yWlkF ]

Publication Contributing Sources